BIO Applauds Senate Passage of the 21st Century Cures Act
Washington, DC (December 7, 2016) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the 21st Century Cures Act by the U.S. Senate:
“The 21st Century Cures Act, passed by the Senate today with overwhelming bipartisan support, is an important victory for medical innovation that will help expedite the development of the next generation of breakthrough medicines to save lives and reduce suffering for millions of patients, while helping to lower other healthcare costs.
“We applaud the work of the Senate for making sure that this important legislation remained a priority. We particularly want to recognize Senate Health, Education, Labor and Pensions (HELP) Chairman Lamar Alexander and Ranking Member Patty Murray, as well as the members of the Committee, for their tireless, bipartisan cooperation in crafting this important legislation. We urge President Obama to swiftly sign the Act into law.”
Read BIO’s letter in support of the 21st Century Cures Act here.
Upcoming BIO Events
BIO CEO & Investor Conference
February 13-14, 2017
New York, NY
BIO International Convention
June 19-22, 2017
San Diego, CA